Home Notifications 1989 Customs Customs - 1989 Customs -Tariff Miscellaneous Exemption Notifications This
Forgot password New User/ Regiser ⇒ Register to get Live Demo
Amends Notification No. 14/86-Cus. - Drug Intermediates - 045/89 - Customs -TariffExtract Amends Notification No. 14/86-Cus. - Drug Intermediates Notification No. 45/89-Cus. Dated 1-3-1989 In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, being satisfied that it is necessary in the public interest so to do, hereby makes the following amendments in the notification of the Government of India in the Ministry of Finance (Department of Revenue) No. 14/88-Customs, dated the 1st March, 1988, namely :- In the said notification, - (i) In the opening paragraph, for the figures and word "29 or 30", the figures and word "29, 30 or 39" shall be substituted; (ii) in the Table,- (a) after Sl. No. 6 and the entries relating thereto, the following Sl. No and entries shall be inserted, namely: - (1) (2) (3) "6A 7ADCA (for manufacture of cephalexin) (a) Bismethyl Silyl Urea (b) Pyridine hydrobromide (c) Peracetic acid"; (b) against Sl. No. 15, in column (3) for the entry, the following entries shall be substituted, namely:- "(a) D-Alpha Dihydro Phenyl Glycine (b) Dihydrophenyl Glycine Chloride Hydrochloride (c) Dihydrophenyl Glycine Base (d) Bistrimethyl Silyl Urea (e) Dimethyl formamide"; (c) against Sl.No. 23, in column (3), after item (c) and the entries relating thereto, the following shall be inserted namely :- "(d) 2 Chloropyridine (e) Dimethanolamine (f) Para chlorobenzyl cyanide"; (d) after Sl. No. 26 and the entries relating thereto, the following Sl. No. and entries shall be inserted, namely :- (1) (2) (3) "26A Cephalexin Trimethyl Chloro Silazane 26B Chloroquine Phosphate (a) Acetobutyrolactone (b) Diethyl malonate (c) Ethyl orthoformate 26C Cephazolin Sodium (a) Ethyl chloroformate (b) 2 Methyl 5 mercapto 1, 3, 4 thiadiazole (c) Tetrazolyl acetic acid (d) Dimethyl acetamide (e) 7 ACA"; (e) after Sl. No. 39 and the entries relating thereto, the following Sl. No. and entries shall be inserted, namely:- (1) (2) (3) "39A Dane Salt (for manufac ture of semi synthetic penicillin) D parahydroxy phenyl glycine base 39B Di-iodochloro hydroxy quinoline 8 Hydroxyquinoline"; (f) for Sl. No. 46, and the entries relating thereto, the following Sl. No. and entries shall be inserted, namely: (1) (2) (3) "46 Folic acid (a) P-Nitrobenzoic acid (b) Dimethyl formamide (c) Sodium cyanide (d) sodium metal"; (g) against Sl. No. 51, in column (3), after item (d) and the entries relating thereto, the following entries shall be inserted, namely : "(e) 2 Chloro propionic acid (f) Neopentyl glycol"; (h) after Sl. No. 54 and the entries relating thereto, the following Sl. No. and entries shall be inserted, namely:- (1) (2) (3) "54A Iodo-chlorohydroxy quinoline 8 Hydroxyquinoline"; (i) against Sl. No. 61, in column (3), after item (e) and the entries relating thereto, the following entries shall be inserted, namely:- "(f) Vanillin"; (j) after Sl. No. 74 and the entries relating thereto, the following Sl. No. and entries shall be inserted, namely:- (1) (2) (3) "74A Oxytocin (a) Nona-peptide (b) Protected hexapeptide (c) Tripeptide hydrazide"; (k) after Sl. No. 76 and the entries relating therto, the following Sl. No. and entries shall be inserted, namely:- (1) (2) (3) "76A Penicillin G Phenyl acetic acid and its salts"; (l) against Sl. No. 83, in column (3), for the entry, the following entries shall be substituted, namely:- " (a) Ethyl- (O- cyano, O- ethyl, O- phenyl) acetate (b) Benzyl cyanide (c) Sodium metal"; (m) Against Sl. No. 88, in column (3), for the entries, the following entries shall be substituted, namely:- " (a) 2 Methyl pyrazine (b) Di cyano pyrazine (c) Quinoxalene (d) Diamino malinonitrile"; (n) After Sl. No. 89 and the entries relating thereto, the following Sl. No. and entries shall be inserted, namely:- (1) (2) (3) "89A Procaine hydrochloride P- Nitrobenzoic acid"; (o) against Sl. No. 90,- (i) in column (2), for the entry, the entry, "Ranitdine/Ranitdine Hydrochloride" shall be substituted; (ii) in column (3), after item (c) and the entries relating thereto, the following shall be inserted, namely :- " (d) 5 Dimethyl aminomethyl 2- (2 aminoethyl thiomethyl) Furane i.e. Cistofer"; (p) after Sl. No. 90 and the entries relating thereto, the following Sl. No. and entries shall be inserted, namely:- (1) (2) (3) "90A Rifampicin Sodium diethyl barbiturate"; (q) after Sl. No. 95 and the entries relating thereto, the following Sl. Nos. and entries shall be inserted, namely:- (1) (2) (3) "95A Salbutamol sulphate (a) Para hydroxy acetophenone (b) Sodium borohydrate (c) N- benzyl tertiary butylamine 95B Sodium PAS Methyl isobutyl ketone 95C Sulphadimidine (a) Acetyl acetone (b) methyl isobutyl ketone 95D Sulphaguanidine Methyl isobutyl ketone 95E Synthetic caffeine NM Dimethyl urea"; (r) after Sl. No. 109 and the entries relating thereto, the following Sl. No. and entries shall be inserted, namely:- (1) (2) (3) "109A Trimethyl benzalde hyde (for manufacture of trimethoprim) Vanillin"; (s) after Sl. No. 110 and the entries relating thereto, the following Sl. Nos. and entries shall be inserted, namely:- (1) (2) (3) "110A Vitamin B 1 (a) Acetobutyrolactone (b) Sodium metal 110B Vitamin B 2 Barbituric acid"; (t) after Sl. No. 111 and the entries relating thereto, the following Sl. No. and entries shall be substituted, namely:- (1) (2) (3) "111 Vitamin B 6 (a) 4 Methyl 5 ethoxazole (b) Cis- butenediol (c) Dl- Alanine (d) Dimethyl formamide (e) Isobutyl aldehyde (f) Ethyl acetoacetate (g) Butenediol".
|